Vladimir Skljarevski

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Vladimir Skljarevski, Manjit Matharu, Brian A. Millen et al. · Cephalalgia · 2018 · 540 citations

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Amy S. Chappell, Melissa J. Ossanna, Hong Liu‐Seifert et al. · Pain · 2009 · 297 citations

Pain Therapy, Pain Disorders, Pain Medicine +20

Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Solomon Tesfaye, Stefan Wilhelm, Alberto Lledó et al. · Pain · 2013 · 296 citations

Pain Therapy, Pain Disorders, Bpi-msf Severity Items +16

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

Robert H. Dworkin, Dennis C. Turk, Sarah Peirce‐Sandner et al. · Pain · 2012 · 276 citations

Pain Therapy, Pain Medicine, Pharmacotherapy +17

A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee

Amy S. Chappell, D. Desaiah, Hong Liu‐Seifert et al. · Pain Practice · 2010 · 220 citations · Full text